Search results
Is Trending Stock Royal Caribbean Cruises Ltd. (RCL) a Buy Now?
Royal Caribbean (RCL) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the
Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?
Catalyst Pharmaceutical (CPRX) closed the last trading session at $26.19, gaining 12.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Banc of California (BANC) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Banc of California (BANC) reports results for the quarter ended March 2026. While this widely-known consensus
Discovery: Starkes Wachstum, steigender Cashflow, Bohrerfolge und neue Optionen!
HA Sustainable Infrastructure Capital (HASI) Upgraded to Buy: Here's Why
HA Sustainable Infrastructure Capital (HASI) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
Bristol Myers’ BMY CAR T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel) posted strong growth in 2025.
Breyanzi is a CD19-directed CAR T cell therapy with a 4-1BB costimulatory domain
Cameco (CCJ) Beats Stock Market Upswing: What Investors Need to Know
Cameco (CCJ) ended the recent trading session at $119.11, demonstrating a +2.63% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.8%. Elsewhere, the
Main Street Capital (MAIN) Beats Stock Market Upswing: What Investors Need to Know
In the latest close session, Main Street Capital (MAIN) was up +2.55% at $57.83. This move outpaced the S&P 500's daily gain of 0.8%. On the other hand, the Dow registered a loss of 0.15%, and the
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.60, marking a +1.91% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.8%
Annaly Capital Management (NLY) Outperforms Broader Market: What You Need to Know
Annaly Capital Management (NLY) closed the most recent trading day at $22.64, moving +1.07% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.8% for the
Kinsale Capital Group, Inc. (KNSL) Surpasses Market Returns: Some Facts Worth Knowing
Kinsale Capital Group, Inc. (KNSL) ended the recent trading session at $358.00, demonstrating a +2.14% change from the preceding day's closing price. The stock's change was more than the S&P 500's
EQS-News: Deutsche Rohstoff AG: Einladung zu den Conference Calls zum Geschäftsbericht 2025 für Investoren, Analysten und Medien
EQS-News: Deutsche Beteiligungs AG: Cartonplast schließt Infrastruktur-Refinanzierung erfolgreich ab und stärkt seine Position für weiteres Wachstum
EQS-News: artec technologies AG und VOMATEC Innovations GmbH starten KI-Forschungsprojekt CAVISIKI: Neue Plattform für intelligente Alarmbewertung und standardisierte Systemintegration in Leitstellen
Should You Invest in the Vanguard Health Care Index Fund ETF Shares (VHT)?
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Vanguard Health Care Index Fund ETF Shares (VHT), a passively managed exchange
These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
The
Want Better Returns? Don't Ignore These 2 Finance Stocks Set to Beat Earnings
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
The
Want Better Returns? Don't Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
We know
Argan Targets 12-Project Capacity: Are Wins Improving Visibility?
Argan, Inc. AGX is targeting the ability to execute 10–12 projects simultaneously, reflecting its practical operating capacity rather than a fixed strategic ceiling. At the end of fiscal 2026, the





